Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide

US8188270B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Alfons Grunenberg · Wuppertal, DE
• Jana Lenz · Wuppertal, DE
• Gerhard Braun · Recklinghausen, DE
• Birgit Keil · Düsseldorf, DE
• Christian Thomas · Wuppertal, DE

Key dates

• Filing date: Sep 22, 2006
• Grant date: May 29, 2012
• Expiry date: May 20, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a novel polymorphic form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene-carboxamide, processes for their preparation, medicaments comprising these forms, and their use in the control of diseases.